Author： Bossi Paolo Locati Laura Licitra Lisa
Publisher： Informa Healthcare
ISSN： 1472-8214
Source： Expert Opinion on Emerging Drugs, Vol.18, Iss.4, 2013-12, pp. : 445-459
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Emerging tyrosine kinase inhibitors for esophageal cancer
By Ku Geoffrey Y Ilson David H
Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. :
Access to resources
Recommend
Emerging drugs for head and neck cancer
By Rhee John C Khuri Fadlo R Shin Dong M
Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. :
Protein tyrosine kinase inhibitors in cancer treatment
By Traxler P.M.
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 6, 1997-06 ,pp. :
Tyrosine kinase inhibitors in cancer treatment (Part II)
By Traxler P.
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. :
Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer
Current Drug Targets, Vol. 10, Iss. 6, 2009-06 ,pp. :